Trials / Suspended
SuspendedNCT00635297
Percutaneous Vertebroplasty: Prophylactic Treatment of Adjacent Vertebra
Percutaneous Vertebroplasty.Study of Refracture Rates After Prophylactic Vertebroplasty of Adjacent Vertebrae
- Status
- Suspended
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Ullevaal University Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Percutaneous vertebroplasty is a treatment for painful osteoporotic compression fractures. Multiple reports have shown as high as 20 % refracturerates in vertebrae adjacent to those that have been treated with percutaneous vertebroplasty. The purpose of the study is to determine if prophylactic vertebroplasty of unfractured vertebrae adjacent to the treated fractured vertebrae can reduce the rates of refracture in adjacent vertebrae.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Percutaneous vertebroplasty | PMMA injection 3-10 milliliter in each treated vertebrae |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2009-04-01
- Completion
- 2009-04-01
- First posted
- 2008-03-13
- Last updated
- 2010-03-03
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT00635297. Inclusion in this directory is not an endorsement.